Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2007
04/25/2007CN1953773A Preservative for medical devices
04/25/2007CN1953770A X-ray visible drug delivery device
04/25/2007CN1953769A Dietary supplement and method for treating digestive system-related disorders
04/25/2007CN1953762A Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound
04/25/2007CN1953757A Composition for cleaning intestinal canal
04/25/2007CN1953756A Insulin resistance improving agent
04/25/2007CN1953755A Method for enhancing life activity and /or expanding suitable region for life activity of living body contacting to water-based environment
04/25/2007CN1953754A Peritoneal dialysis solution
04/25/2007CN1953753A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate
04/25/2007CN1953752A Treatment of interstitial cystitis with vitamin D compounds
04/25/2007CN1953751A Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other HIV inhibitors
04/25/2007CN1953750A Novel uses for proton pump inhibitors
04/25/2007CN1953748A A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer
04/25/2007CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer
04/25/2007CN1953746A Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
04/25/2007CN1953745A Combinations of glycopyrrolate and beta2 adrenoceptor agonists
04/25/2007CN1953744A Combination of a DNA topoisomerase inhibitor and an IAP inhibitor
04/25/2007CN1953743A Topical co-enzyme Q10 formulations and methods of use
04/25/2007CN1953742A Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition
04/25/2007CN1953741A Solid formulations of ospemifene
04/25/2007CN1953740A Method of treating dry eye disorders and uveitis
04/25/2007CN1953670A Composition, use of a composition and a method for treating obesity
04/25/2007CN1953660A Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
04/25/2007CN1952126A Molecule transfer/delivery system and molecule transfer /delivery method
04/25/2007CN1951952A Triterpene compound for preparing drug for treating cranial glia tumour
04/25/2007CN1951950A Helicid modifier and its preparation method and uses
04/25/2007CN1951949A N-alkylated 1,6-bideoxyazaglucide compound, its synthesis method and uses
04/25/2007CN1951939A Novel pyrrole derivatives as pharmaceutical agents
04/25/2007CN1951938A Penehyclidine quaternary ammonium salt and its derivative
04/25/2007CN1951932A [N-(3',4'methylenedioxy)phenylethyl] formamidobenzoic acid derivative, its preparation method and uses
04/25/2007CN1951923A Sulfur-containing quinoxaline dioxide, method for producing same and their application
04/25/2007CN1951919A Milrinone salt preparation method and its uses
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/25/2007CN1951907A Compound and its preparation method and its application in pharmacy
04/25/2007CN1951899A Aspirin-triggered lipid mediators
04/25/2007CN1951896A Benzobinaphthoquinone derivative with anticancer activity
04/25/2007CN1951502A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
04/25/2007CN1951501A Pharmaceutical composition with Meclofenoxate hydrochloride capable of preventing hydrolysis
04/25/2007CN1951496A Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure
04/25/2007CN1951484A Oil for treating wounds
04/25/2007CN1951483A Hybrid safflower oil and preparation method thereof
04/25/2007CN1951480A Medicament for treating type 2 diabetes
04/25/2007CN1951458A Instant acting medicament for treating rhinitis
04/25/2007CN1951454A Antiinflammation ointment plaster for treating tonsillitis
04/25/2007CN1951453A Chinese medicinal granule for treating piles and preparation method thereof
04/25/2007CN1951445A Itching relieving lotion and preparation method thereof
04/25/2007CN1951444A Medicament for treating prolonged skin ulceration and preparation method thereof
04/25/2007CN1951428A Chinese medicinal composition for treating traumatic diseases, its preparation method and quality control method
04/25/2007CN1951419A Capsule for treating cough, asthma and pharyngitis
04/25/2007CN1951413A Medicament for preventing and treating turtle disease and preparation method thereof
04/25/2007CN1951412A Nitric oxide and its biomedical significance
04/25/2007CN1951411A Nitric oxide and its biomedical significance
04/25/2007CN1951410A Protecting agent for brain cell or nerve cell, consisting of ginseng
04/25/2007CN1951406A Drop pills for treating coronary heart disease, angina pectoris and preparation method thereof
04/25/2007CN1951397A Physiological balanced nutrient with physiological balanced calcium
04/25/2007CN1951396A Effective part of sweet wormwood, its preparation method and application thereof in pharmacy
04/25/2007CN1951395A Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug
04/25/2007CN1951394A Application of Antitumor Saponins OSW-1 in preparation of anti-cancer medicament
04/25/2007CN1951393A Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof
04/25/2007CN1951392A Compound medicament composed of gastrodine and ligustrazine
04/25/2007CN1951391A Method for preparing suspension of rhodiola root nanoliposome
04/25/2007CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide
04/25/2007CN1951389A Composition of Essentiale Phospholipids injection and preparation method thereof
04/25/2007CN1951388A Betamethasone sodium phosphate powder injection and preparation method thereof
04/25/2007CN1951387A Medicinal combinations composed by Imipenem, Cilastatin and three kinds of sputum removing medicament
04/25/2007CN1951386A Medicinal combinations composed by meropenem with three kinds of sputum removing medicament respectively
04/25/2007CN1951385A Minipills containing simvastatin and derivative thereof and method for preparing formulation thereof
04/25/2007CN1951384A Pharmaceutical composition for treating cerebrovascular diseases and preparation method thereof
04/25/2007CN1951383A Stabilized medical and cosmetic composition containing catechin
04/25/2007CN1951382A Oral formulation of neogambogic acid for treating tumor
04/25/2007CN1951381A Baicalin solution composition
04/25/2007CN1951380A Medical usage of salvianolic acid B salt and total salvianolic acid
04/25/2007CN1951379A Medicinal combination composed by Fudosteine with nine kinds of antiseptic medicament respectively
04/25/2007CN1951378A Medical usage of 2beta-hydroxyilicicacid in inhibiting hepatitis B
04/25/2007CN1951377A A colorless transparent healthcare drop used in cigarette
04/25/2007CN1951376A Novel medical usage of protocatechualdehyde
04/25/2007CN1951375A Nicotine transdermal formulation and its production method
04/25/2007CN1951373A Method for preparing nimodipine dispersible tablet with high dissolution
04/25/2007CN1951372A Solid oral dosage forms comprising valsartan and HCTZ
04/25/2007CN1951371A Immediate release tablet
04/25/2007CN1951370A Method for preparing solid dispersible minipills of Simvastatin
04/25/2007CN1951369A Coated nanoliposomes of resveratrol and preparation method thereof
04/25/2007CN1951368A Oral resveratrol multi-phase liposome and preparation method thereof
04/25/2007CN1951367A Fat emulsion containing hydroxycamptothecine and preparation method thereof
04/25/2007CN1951243A Method for preparing medicinal lining for preventing and treating mammary glands hyperplasia and application thereof
04/25/2007CN1312285C Process for producing 1,4-dihydroxy-2-naphthoic acid
04/25/2007CN1312170C Technique of preparing extract product of 'Liangtoujian' and its application in preparing medication of treating cancer
04/25/2007CN1312169C Preparation of gentian effective part and its application
04/25/2007CN1312167C Epimedium extract and its production method
04/25/2007CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same
04/25/2007CN1312161C 3-hydroxy-4,3',4',5'-tetromethoxy bibenzyl phosphate and its composition, prepn and application
04/25/2007CN1312157C Halogenated dihydroartemisine, preparation and use thereof
04/25/2007CN1312154C Purine derivatives as kinase inhibitors
04/25/2007CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use
04/25/2007CN1312152C New purine derivatives
04/25/2007CN1312151C (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker
04/25/2007CN1312148C Isochroman compounds for treatment of CNS disorders
04/25/2007CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists
04/25/2007CN1312142C Diaryl neptanone compound and its preparing method
04/25/2007CN1312140C Lipid lowering biphenylcarboxamides
1 ... 3784 3785 3786 3787 3788 3789 3790 3791 3792 3793 3794 3795 3796 3797 3798 3799 3800 3801 3802 3803 3804 ... 7860